1. Baseline total metabolic tumour volume on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography-computed tomography as a promising biomarker in patients with advanced non–small cell lung cancer treated with first-line pembrolizumab. (June 2021) Authors: Dall'Olio, Filippo G.; Calabrò, Diletta; Conci, Nicole; Argalia, Giulia; Marchese, Paola Valeria; Fabbri, Francesca; Fragomeno, Benedetta; Ricci, Dalia; Fanti, Stefano; Ambrosini, Valentina; Ardizzoni, Andrea Journal: European journal of cancer Issue: Volume 150(2021) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors. (October 2020) Authors: Dall'Olio, Filippo G.; Abbati, Francesca; Facchinetti, Francesco; Massucci, Maria; Melotti, Barbara; Squadrilli, Anna; Buti, Sebastiano; Formica, Francesca; Tiseo, Marcello; Ardizzoni, Andrea Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients – A single centre experience. (November 2020) Authors: Dall'Olio, Filippo G.; Conci, Nicole; Rossi, Giulio; Fiorentino, Michelangelo; De Giglio, Andrea; Grilli, Giada; Altimari, Annalisa; Gruppioni, Elisa; Filippini, Daria M.; Di Federico, Alessandro; Nuvola, Giacomo; Ardizzoni, Andrea Journal: Lung cancer Issue: Volume 149(2020) Page Start: 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ECOG performance status ≥2 as a prognostic factor in patients with advanced non small cell lung cancer treated with immune checkpoint inhibitors—A systematic review and meta-analysis of real world data. (July 2020) Authors: Dall'Olio, Filippo G.; Maggio, Ilaria; Massucci, Maria; Mollica, Veronica; Fragomeno, Benedetta; Ardizzoni, Andrea Journal: Lung cancer Issue: Volume 145(2020) Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC. (February 2022) Authors: Dall'Olio, Filippo G.; Parisi, Claudia; Marcolin, Laura; Brocchi, Stefano; Caramella, Caroline; Conci, Nicole; Carpani, Giulia; Gelsomino, Francesco; Ardizzoni, Stefano; Marchese, Paola Valeria; Paccapelo, Alexandro; Grilli, Giada; Golfieri, Rita; Besse, Benjamin; Ardizzoni, Andrea Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC. (November 2021) Authors: Dall'Olio, Filippo G.; Parisi, Claudia; Marcolin, Laura; Brocchi, Stefano; Caramella, Caroline; Conci, Nicole; Carpani, Giulia; Gelsomino, Francesco; Ardizzoni, Stefano; Marchese, Paola Valeria; Paccapelo, Alexandro; Grilli, Giada; Golfieri, Rita; Besse, Benjamin; Ardizzoni, Andrea Journal: Therapeutic advances in medical oncology Issue: Volume 13(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗